ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Solarcaïne®:VERFORA SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
D04AB01 - LidocaineATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D04 - Antipruritics, incl. Antihistamines, Anesthetics, Etc.
 
D04A - Antipruritics, incl. Antihistamines, Anesthetics, Etc.

This group comprises antipruritics for topical use in the treatment of pruritus, minor burns, insect stings, herpes zoster etc.
See also D07 - Corticosteroids, dermatological preparations.

D04AB - Anesthetics for Topical Use

At each 5th plain level, antiseptics, siccants etc. may occur in combination with the anesthetics. Combinations with corticosteroids, see D07 - Corticosteroids, dermatological preparations.
Combinations with antihistamines are classified in D04AB at the corresponding plain 5th level.
See also C05A - Agents for treatment of hemorrhoids and anal fissures for topical use, and N01B - Anesthetics, local.

D04AB01 - Lidocaine
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home